NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the NRX Pharmaceuticals Incorporated second quarter 2023 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. And to withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Mr. Matthew Duffy, the company's chief business officer. Please go ahead, sir. Thank you, Chuck. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal security laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from the historical experience or present our expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC. The forward-looking statements made during this call speak only as of the date to hear of, and the company undertakes no obligation to update and revise the forward-looking statements. Information presented on this call is contained in the press release issued earlier today and in the company's form TED-Q filed today. which may be accessed from the investor page of the NRX Pharmaceuticals Incorporated website. Joining me on the call are Stephen Willard, our Chief Executive Officer, Jonathan Javik, our Chief Scientist, and Seth VanBoordies, our Chief Financial Officer and Treasurer. Stephen and Jonathan will provi...